retatrutide ly3437943 clinical trial results in healthy participants in a phase 1 single ascending dose Retatrutide for Obesity · Info
Description
In both cases, these medications are intended to be used long-term in combination with lifestyle interventions to support overall wellbeing
Peters JH, McKay BM, Simasko SM, Ritter RC
"They didn't give me a choice," he says
1 This press release features multimedia
Methods GLP-1 agonists included in the analysis were approved for treatment of obesity (Saxenda, Wegovy, Zepbound) and corresponding formulations that may potentially be used off-label for treatment of obesity (Mounjaro, Ozempic, Rybelsus, Victoza)
[DOI] [PubMed] [Google Scholar] 398.Sharma, M
